Literature DB >> 9233717

Chronically rejected rat kidney allografts induce donor-specific tolerance.

S G Tullius1, M Nieminen, W O Bechstein, S Jonas, T Steinmüller, J Pratschke, K Zeilinger, E Graser, H D Volk, P Neuhaus.   

Abstract

Previous studies on pathophysiological mechanisms of chronic graft rejection demonstrated the impact of both alloresponsiveness and nonspecific immunological events on the process. To study the role of alloantigen-specific factors further, we hypothesized an acceleration of chronic graft rejection after presensitization. Chronically rejected renal allografts in the established Fischer 344 --> Lewis rat model were replaced sequentially by native allografts of donor origin. Grafting of second allografts was performed 2, 4, 8, and 12 weeks after the original transplantation and followed long term. Second allografts demonstrated significantly ameliorated functional and structural alterations with few cellular infiltrates. These changes were independent from the time interval between first and second engraftment (2-12 weeks); immunosuppressive treatment after the second engraftment was not influential. The nonresponsiveness was not restricted to the second kidney allografts, as heart allografts of donor origin in these recipients also functioned indefinitely, whereas third-party grafts (Lewis x Brown Norway F1) and Fischer 344 heart grafts in untreated Lewis control rats were acutely rejected. Thus, donor-specific and tissue-nonspecific graft acceptance is achieved by second engraftment of donor-specific allografts in a model of chronic graft rejection. Those observations demonstrate the synergistic effects of alloresponsiveness and of the injured graft itself for the development of chronic graft failure.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9233717     DOI: 10.1097/00007890-199707150-00027

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  5 in total

Review 1.  Regulatory immune cells in transplantation.

Authors:  Kathryn J Wood; Andrew Bushell; Joanna Hester
Journal:  Nat Rev Immunol       Date:  2012-05-25       Impact factor: 53.106

2.  Late blockade of T cell costimulation interrupts progression of experimental chronic allograft rejection.

Authors:  A Chandraker; H Azuma; K Nadeau; C B Carpenter; N L Tilney; W W Hancock; M H Sayegh
Journal:  J Clin Invest       Date:  1998-06-01       Impact factor: 14.808

3.  Donor-specific antibodies after ceasing immunosuppressive therapy, with or without an allograft nephrectomy.

Authors:  Arnaud Del Bello; Nicolas Congy-Jolivet; Federico Sallusto; Celine Guilbeau-Frugier; Isabelle Cardeau-Desangles; Marylise Fort; Laure Esposito; Joelle Guitard; Olivier Cointault; Laurence Lavayssière; Marie Béatrice Nogier; Antoine Blancher; Lionel Rostaing; Nassim Kamar
Journal:  Clin J Am Soc Nephrol       Date:  2012-05-24       Impact factor: 8.237

4.  Increasing transplant mass results in long-term allograft survival and recovery from transplant vasculopathy.

Authors:  De Shon Hall; Edda M Roberts; Sharon Ferguson; Zhuangzhi Wang; Joanna D Davies
Journal:  J Clin Immunol       Date:  2003-05       Impact factor: 8.317

5.  Significant association between FOXP3 gene polymorphism and steroid-resistant acute rejection in living donor liver transplantation.

Authors:  Sapana Verma; Yuka Tanaka; Seiichi Shimizu; Naoki Tanimine; Hideki Ohdan
Journal:  Hepatol Commun       Date:  2017-06-08
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.